Urinary Kininogen: A Possible Regulator of Kinin Formation in Normal Individuals and Subjects with Essential Hypertension, End-Stage Renal and Liver Disease
Most previous studies have not significantly correlated urinary kallikrein to urinary kinins. We investigated whether urinary kininogen might influence kinin formation within the urine. On an ad-lib diet the 24 hour excretion of total and intact kininogen, kinins and kallikrein was determined in 24 control subjects, 20 untreated essential hypertensives, 12 vith end-stage renal disease and 8 subjects with liver disease. Kallikrein and kinins were measured by a direct radioimmunoassay. Total kininogen was determined from the sum of preformed kinins and kinins generated after trypsin (intact kininogen), Cross reactivity between purified human low molecular weight kininogen and bradykinin antiserum was 3%. Total and intact kininogen were significantly correlated with kinins in controls, essential hypertension and liver disease. In essential hypertension, end-stage renal and liver diseases kinins were significantly decreased. This was associated with a reduction in kininogen but not kallikrein in essential hypertension and liver disease, and a reduction in kallikrein but not kininogen in end-stage renal disease. Thus, renal kinin generation in various states may be affected by either or both kininogen and kallikrein.
KeywordsLiver Disease Essential Hypertension Urinary Sodium Endogenous Kinin Urinary Kallikrein
Unable to display preview. Download preview PDF.
- 1.N. G. Levinsky, The renal kallikrein-kinin system, Circ. Res., 44: 441–451, (1979).Google Scholar
- 4.J. J. Pisano, J. Corthorn, K. Yates, and J. V. Pierce: The kallikrein-kinin system in the kidney, Controv. Nephrol., 12: 116–125, (1978).Google Scholar
- 6.D. Proud, M. Perkins, J. V. Pierce, K. N. Yates, P. F. Highet, P. L. Herring, M. Mangkornkanok/Mark, R. Bahu, F. Carone, and J. J. Pisano, Characterization and localization of human renal kininogen, J. Biol. Chem., 256: 10634–10639, (1981).Google Scholar
- 7.M. S. Weinberg, C. A. St. Martin, P. Azar, M. Taylor, W. M. Trebbin, and R. J. Solomon, Urokininogen: A possible regulator of the kallikrein-kinin system, Clin. Res., 32: 459A, (1984).Google Scholar
- 9.V. Hial, H. R. Keiser, and J. J. Pisano, Origin and content of methionyl-lysyl-bradykinin, lysyl-bradykinin and bradykinin in human urine, Biochem. Pharmacol., 25: 2499–2503, (1976).Google Scholar
- 10.M. S. Weinberg, N. B. Oza, and N. G. Levinsky, Components of the kallikrein-kinin system in rat urine, Biochem. Pharmacol., 33: 1779–1782, (1984).Google Scholar
- 11.N. B. Oza, W. Lieberthal, D. B. Bernard, and N. G. Levinsky, Anti body that recognizes total human urinary kallikrein, Radioimmunological determination of inactive kallikrein, J. Immunol., 126: 2361–2364, (1983).Google Scholar
- 13.B. E. Huitema, The analysis of covariance and alternatives, John Wiley & Sons, New York, NY, pp. 238–240.Google Scholar
- 14.F. N. Kerlinger and E. J. Pedhazer, Multiple regression in behavioral research, Holt, Rinehart & Winston, Inc., New York, NY, pp. 83.Google Scholar
- 17.J. V. Pierce and J. A. Guimaraes, Further characterization of highly purified human plasma kininogens, in: The Chemistry and Biology of the kallikrein-Kinin System in Health and Disease by J. J. Pisano and K. F. Austen, eds., U. S. Government Printing Office, Washington, D. C., pp. 121–128, (1977).Google Scholar